N/A
N=312
PRogram In Support of Moms: An Innovative Stepped-Care Approach for Obstetrics and Gynecology Clinics
Depression
Bottom Line
View on ClinicalTrials.gov: NCT02760004 ↗Enrolled (actual)
312
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Change in Edinburgh Postnatal Depression Scale Score (EPDS) — -4.3; -4.2 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PRogram In Support of Moms (PRISM) (Behavioral); MCPAP for Moms (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Massachusetts, Worcester
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Edinburgh Postnatal Depression Scale Score (EPDS) |
-4.3; -4.2 | — |
| SECONDARY Participants Initiating Treatment |
78; 70 | — |
| SECONDARY Participants Sustaining Mental Health Treatment |
38; 32 | — |
Summary
The primary goal of this study is to develop, evaluate, and share a new low-cost program for Obstetrics/Gynecology (Ob/Gyn) practices which will help to improve depression treatment for women during pregnancy and after childbirth.
Eligibility Criteria
Inclusion Criteria
- Female
- Age 18-55 years
- English speaking
- >4 weeks Gestational age (GA) until 4 months postpartum
- Receiving care from one of the 10 participating practices (five will participate in PRISM (intervention group) and five will have access to MCPAP For Moms (comparison group)
- Edinburgh Postnatal Depression Scale score (EPDS) ≥10
- Able to communicate in written and spoken English; and
- Cognitively able to participate in informed verbal consent
Exclusion Criteria
- Lack of verbal and written English fluency
- Under age 18 or over age 55
- substance use disorder as determined by the questions in 4 Ps questionnaire
- Screen positive for bipolar disorder via the Mood Disorder Questionnaire (MDQ)
- Prisoner
- Women participating in 'Moms do care' study
Data sourced from ClinicalTrials.gov (NCT02760004). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.